These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25581441)
21. Noninvasive Detection of HER2 Expression in Gastric Cancer by Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865 [TBL] [Abstract][Full Text] [Related]
22. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma. Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955 [TBL] [Abstract][Full Text] [Related]
23. Immuno-PET of tissue factor in pancreatic cancer. Hong H; Zhang Y; Nayak TR; Engle JW; Wong HC; Liu B; Barnhart TE; Cai W J Nucl Med; 2012 Nov; 53(11):1748-54. PubMed ID: 22988057 [TBL] [Abstract][Full Text] [Related]
24. PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment. Shi S; Orbay H; Yang Y; Graves SA; Nayak TR; Hong H; Hernandez R; Luo H; Goel S; Theuer CP; Nickles RJ; Cai W J Nucl Med; 2015 Jun; 56(6):927-32. PubMed ID: 25883125 [TBL] [Abstract][Full Text] [Related]
25. Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology? Papadimitriou K; Kountourakis P; Kottorou AE; Antonacopoulou AG; Rolfo C; Peeters M; Kalofonos HP Mol Diagn Ther; 2016 Dec; 20(6):523-530. PubMed ID: 27392476 [TBL] [Abstract][Full Text] [Related]
26. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379 [TBL] [Abstract][Full Text] [Related]
27. ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models. Li C; Kang L; Fan K; Ferreira CA; Becker KV; Huo N; Liu H; Yang Y; Engle JW; Wang R; Xu X; Jiang D; Cai W Bioconjug Chem; 2021 Jul; 32(7):1306-1314. PubMed ID: 33475350 [TBL] [Abstract][Full Text] [Related]
28. Targeting Phosphatidylserine with a Perreault A; Richter S; Bergman C; Wuest M; Wuest F Mol Pharm; 2016 Oct; 13(10):3564-3577. PubMed ID: 27608290 [TBL] [Abstract][Full Text] [Related]
29. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence. Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463 [TBL] [Abstract][Full Text] [Related]
31. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14). Fournier P; Dumulon-Perreault V; Ait-Mohand S; Tremblay S; Bénard F; Lecomte R; Guérin B Bioconjug Chem; 2012 Aug; 23(8):1687-93. PubMed ID: 22770480 [TBL] [Abstract][Full Text] [Related]
32. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule. Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877 [TBL] [Abstract][Full Text] [Related]
33. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452 [TBL] [Abstract][Full Text] [Related]
34. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors. Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694 [TBL] [Abstract][Full Text] [Related]
35. Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases. Siraj A; Desestret V; Antoine M; Fromont G; Huerre M; Sanson M; Camparo P; Pichon C; Planeix F; Gonin J; Radu A; Ghinea N BMC Cancer; 2013 May; 13():246. PubMed ID: 23688201 [TBL] [Abstract][Full Text] [Related]
36. ImmunoPET Imaging of α White JB; Hu LY; Boucher DL; Sutcliffe JL Mol Imaging Biol; 2018 Feb; 20(1):103-113. PubMed ID: 28653240 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer. Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015 [TBL] [Abstract][Full Text] [Related]
38. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen. Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418 [TBL] [Abstract][Full Text] [Related]
39. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments. Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837 [TBL] [Abstract][Full Text] [Related]
40. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model. Lane SR; Nanda P; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Jurisson SS; Smith CJ Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]